Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 3Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Other 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Malnutrition 1Fatigue 1Depression 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Nutritional Support × Breast × Clear all
NCT01802346 2026-06-05

Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

University of Southern California

Phase NA Active not recruiting
130 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT00037024 2017-02-23

Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer

Duke University

Phase NA Completed
BreastGenitourinary

Breast Neoplasms, Depression, Fatigue, Prostatic Neoplasms, Breast Neoplasms, Male, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡